Tuesday, September 29, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchmacrocyclic peptidesrippscyclic peptidesenzymology

P450 enzyme KwwB installs non-native Tyr–Trp cross-link in cyclic peptides

The enzyme also tolerated leader peptide mutations at positions -11 to -2, failing only at the conserved proline at position -4.

PR
By Priya Raman · Science Reporter
Sep 28 09:52 ETSource: Nature

The wire

  1. 01Researchers report that P450 cyptide synthase KwwB from Kitasatospora sp. GAS204B catalyzes a non-native cross-link between Tyr-C3 and Trp-N1 at a YxW motif.
  2. 02Macrocyclization improves proteolytic stability, cell permeability and binding affinity, and promiscuous macrocyclases are a route to new cyclic peptide drug candidates.
  3. 03This is enzymology in a biosynthetic system, not a therapeutic candidate; translation to any specific drug scaffold remains untested.

From the source

P450 cyptide synthase KwwB catalyzes non-native cross-link at Tyr-C3–Trp-N1 and tolerates leader peptide mutations

Cyptides refer to a rapidly growing class of ribosomally synthesized and post-translationally modified peptides (RiPPs) containing biaryl cyclophanes installed by P450 enzymes. Here, we further investigated P450 cyptide synthase KwwB from Kitasatospora sp. GAS204B, which expands the KwwB-catalyzed chemical repertoire to non-native cross-link between Tyr-C3 and Trp-N1 at the YxW motif. In addition,

Read at nature.com
PeptiPrescribed peptides from $99/moSee all →